{"id":"tp-55897","type":"article-newspaper","title":"Absci Eyes December Hair-Loss Data, Reaffirms Mid-2027 Endometriosis Trial Target","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/55897","datePublished":"2026-11-12T20:59:33.000Z","dateModified":"2026-11-12T20:59:33.000Z","language":"en","abstract":"The company expects interim 13-week proof-of-concept findings for ABS-201 in December, followed by full 26-week data in early 2027.","section":"Business","references":[]}